These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 4318071)
1. Antiviral phenoxathiins and their analogs. Study of the structure-activity relationships for antiviral activity and the replacement ability in poliovirus type 3 dependent variants. Paget CJ; Dennis EM; Nelson J; DeLong DC J Med Chem; 1970 Jul; 13(4):620-3. PubMed ID: 4318071 [No Abstract] [Full Text] [Related]
2. The characteristic and relationships of virus resistance and dependence to guanidine and other compounds. Ferrari W; Loddo B; Gessa GL Ann N Y Acad Sci; 1965 Jul; 130(1):404-8. PubMed ID: 4285586 [No Abstract] [Full Text] [Related]
3. Studies of some substances with antiviral activity. 3. The inhibition of poliovirus type 1 and 2 induced cytopathogenic changes in cell cultures of human embryonic kidneys by derivatives of thiazolidine acetic acid. Schauer P; Likar M; Tisler M; Krbavcic A Pathol Microbiol (Basel); 1966; 29(4):506-12. PubMed ID: 4288654 [No Abstract] [Full Text] [Related]
4. Development of resistance to antiviral drugs. Renis HE; Buthala DA Ann N Y Acad Sci; 1965 Jul; 130(1):343-54. PubMed ID: 4285582 [No Abstract] [Full Text] [Related]
5. Differential sensitivity to gliotoxin of virulent and attenuated poliovirus strains and its possible use as a genetic marker. Sergiescu D; Aubert-Combiescu A Arch Gesamte Virusforsch; 1969; 27(2):268-81. PubMed ID: 4313025 [No Abstract] [Full Text] [Related]
6. [Antiviral activity of imidazole derivatives. IV. Sensitivity of different viruses]. Tonew M; Tonew EM; Zöpel P Arch Gesamte Virusforsch; 1971; 34(3):250-4. PubMed ID: 4330139 [No Abstract] [Full Text] [Related]
7. The specific effectors of viral development. Lwoff A Biochem J; 1965 Aug; 96(2):289-301. PubMed ID: 4284431 [No Abstract] [Full Text] [Related]
8. Inhibitory effect of N-phenyl-N'-aryl or alkylthiourea derivatives on poliovirus multiplication in cell cultures. Galabov A; Shindarov L; Vassilev G; Vassileva R Chemotherapy; 1972; 17(3):161-74. PubMed ID: 4338370 [No Abstract] [Full Text] [Related]
9. Potential antiviral agents. Carbobenzoxy di- and tripeptides active against measles and herpes viruses. Nicolaides E; DeWald H; Lipnik M; Westland R; Posler J J Med Chem; 1968 Jan; 11(1):74-9. PubMed ID: 4295313 [No Abstract] [Full Text] [Related]
10. Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride. Schild GC; Sutton RN Br J Exp Pathol; 1965 Jun; 46(3):263-73. PubMed ID: 4284028 [No Abstract] [Full Text] [Related]
11. Identification and Analysis of Antiviral Compounds Against Poliovirus. Leyssen P; Franco D; Tijsma A; Lacroix C; De Palma A; Neyts J Methods Mol Biol; 2016; 1387():325-38. PubMed ID: 26983743 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activity and molecular features of benzimidazoles. O'Sullivan DG; Ludlow C; Pantic D; Wallis AK Antimicrob Agents Chemother (Bethesda); 1969; 9():153-9. PubMed ID: 4319306 [No Abstract] [Full Text] [Related]
13. In vitro antiviral activity of single domain antibody fragments against poliovirus. Thys B; Schotte L; Muyldermans S; Wernery U; Hassanzadeh-Ghassabeh G; Rombaut B Antiviral Res; 2010 Aug; 87(2):257-64. PubMed ID: 20566349 [TBL] [Abstract][Full Text] [Related]
14. The effect of isatin beta thiosemicarbazone (IBT)-related compounds on IBT-resistant and on IBT-dependent mutants of vaccinia virus. Katz E; Margalith E; Winer B J Gen Virol; 1974 Nov; 25(2):239-44. PubMed ID: 4373528 [No Abstract] [Full Text] [Related]
15. Antiviral activity of gliotoxin. Larin NM; Copping MP; Herbst-Laier RH; Roberts B; Wenham RB Chemotherapy; 1965; 10(1):12-23. PubMed ID: 4285752 [No Abstract] [Full Text] [Related]
16. Distinctive features and comparative value of the genetic markers defining the behaviour of poliovirus towards different selective inhibitors. Horodniceanu F; Sergiescu D; Aubert-Combiescu A; Crainic R Prog Immunobiol Stand; 1967; 3():78-81. PubMed ID: 4314440 [No Abstract] [Full Text] [Related]
17. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073. Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515 [TBL] [Abstract][Full Text] [Related]
18. Anti-viral activity of 5,6-dichloro-1-(2'-deoxy-beta-d-ribofuranosyl)benzimidazole and related derivatives. Diwan A; Gowdy CN; Robins RK; Prusoff WH J Gen Virol; 1968 Dec; 3(3):393-402. PubMed ID: 4304103 [No Abstract] [Full Text] [Related]
19. Substituted benzaldehyde thiosemicarbazone with antiviral activity against poliovirus. Andrei GM; Pieroni OI; Gatica HS; Coto CE Drugs Exp Clin Res; 1985; 11(12):869-73. PubMed ID: 3013560 [TBL] [Abstract][Full Text] [Related]
20. Detection and evaluation of potential antiviral drugs. Discussion. Ann N Y Acad Sci; 1965 Jul; 130(1):65-70. PubMed ID: 4285594 [No Abstract] [Full Text] [Related] [Next] [New Search]